Pharma & Healthcare
Global Fatty Liver Drugs Market Insights, Forecast to 2030
- Nov 02, 24
- ID: 653957
- Pages: 106
- Figures: 133
- Views: 2
Fatty liver drugs refer to medications or pharmaceutical treatments used in the management and treatment of fatty liver disease. Fatty liver disease, also known as hepatic steatosis, is a condition characterized by the accumulation of excess fat in the liver cells.
Market Analysis and Insights: Global Fatty Liver Drugs Market
The global Fatty Liver Drugs market is projected to grow from US$ 22040 million in 2024 to US$ 29870 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Fatty Liver Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Fatty Liver Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fatty Liver Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fatty Liver Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Fatty Liver Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Fatty Liver Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Pfizer
Gilead Sciences
Astra Zenca
Immuron
Novartis
Takeda
Allergan
Intercept Pharmaceuticals
Conatus
Merk
Madrigal
Hepion Pharmaceuticals
Segment by Type
ALD
NAFLD
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Fatty Liver Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fatty Liver Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fatty Liver Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Fatty Liver Drugs Market
The global Fatty Liver Drugs market is projected to grow from US$ 22040 million in 2024 to US$ 29870 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Fatty Liver Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Fatty Liver Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fatty Liver Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fatty Liver Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Fatty Liver Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Fatty Liver Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Pfizer
Gilead Sciences
Astra Zenca
Immuron
Novartis
Takeda
Allergan
Intercept Pharmaceuticals
Conatus
Merk
Madrigal
Hepion Pharmaceuticals
Segment by Type
ALD
NAFLD
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Fatty Liver Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fatty Liver Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fatty Liver Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fatty Liver Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 ALD
1.2.3 NAFLD
1.3 Market by Application
1.3.1 Global Fatty Liver Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fatty Liver Drugs Market Perspective (2019-2030)
2.2 Global Fatty Liver Drugs Growth Trends by Region
2.2.1 Fatty Liver Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fatty Liver Drugs Historic Market Size by Region (2019-2024)
2.2.3 Fatty Liver Drugs Forecasted Market Size by Region (2025-2030)
2.3 Fatty Liver Drugs Market Dynamics
2.3.1 Fatty Liver Drugs Industry Trends
2.3.2 Fatty Liver Drugs Market Drivers
2.3.3 Fatty Liver Drugs Market Challenges
2.3.4 Fatty Liver Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Fatty Liver Drugs by Players
3.1.1 Global Fatty Liver Drugs Revenue by Players (2019-2024)
3.1.2 Global Fatty Liver Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Fatty Liver Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Fatty Liver Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Fatty Liver Drugs Market Concentration Ratio
3.4.1 Global Fatty Liver Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fatty Liver Drugs Revenue in 2023
3.5 Global Key Players of Fatty Liver Drugs Head office and Area Served
3.6 Global Key Players of Fatty Liver Drugs, Product and Application
3.7 Global Key Players of Fatty Liver Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fatty Liver Drugs Breakdown Data by Type
4.1 Global Fatty Liver Drugs Historic Market Size by Type (2019-2024)
4.2 Global Fatty Liver Drugs Forecasted Market Size by Type (2025-2030)
5 Fatty Liver Drugs Breakdown Data by Application
5.1 Global Fatty Liver Drugs Historic Market Size by Application (2019-2024)
5.2 Global Fatty Liver Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fatty Liver Drugs Market Size (2019-2030)
6.2 North America Fatty Liver Drugs Market Size by Type
6.2.1 North America Fatty Liver Drugs Market Size by Type (2019-2024)
6.2.2 North America Fatty Liver Drugs Market Size by Type (2025-2030)
6.2.3 North America Fatty Liver Drugs Market Share by Type (2019-2030)
6.3 North America Fatty Liver Drugs Market Size by Application
6.3.1 North America Fatty Liver Drugs Market Size by Application (2019-2024)
6.3.2 North America Fatty Liver Drugs Market Size by Application (2025-2030)
6.3.3 North America Fatty Liver Drugs Market Share by Application (2019-2030)
6.4 North America Fatty Liver Drugs Market Size by Country
6.4.1 North America Fatty Liver Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Fatty Liver Drugs Market Size by Country (2019-2024)
6.4.3 North America Fatty Liver Drugs Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Fatty Liver Drugs Market Size (2019-2030)
7.2 Europe Fatty Liver Drugs Market Size by Type
7.2.1 Europe Fatty Liver Drugs Market Size by Type (2019-2024)
7.2.2 Europe Fatty Liver Drugs Market Size by Type (2025-2030)
7.2.3 Europe Fatty Liver Drugs Market Share by Type (2019-2030)
7.3 Europe Fatty Liver Drugs Market Size by Application
7.3.1 Europe Fatty Liver Drugs Market Size by Application (2019-2024)
7.3.2 Europe Fatty Liver Drugs Market Size by Application (2025-2030)
7.3.3 Europe Fatty Liver Drugs Market Share by Application (2019-2030)
7.4 Europe Fatty Liver Drugs Market Size by Country
7.4.1 Europe Fatty Liver Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Fatty Liver Drugs Market Size by Country (2019-2024)
7.4.3 Europe Fatty Liver Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Fatty Liver Drugs Market Size (2019-2030)
8.2 China Fatty Liver Drugs Market Size by Type
8.2.1 China Fatty Liver Drugs Market Size by Type (2019-2024)
8.2.2 China Fatty Liver Drugs Market Size by Type (2025-2030)
8.2.3 China Fatty Liver Drugs Market Share by Type (2019-2030)
8.3 China Fatty Liver Drugs Market Size by Application
8.3.1 China Fatty Liver Drugs Market Size by Application (2019-2024)
8.3.2 China Fatty Liver Drugs Market Size by Application (2025-2030)
8.3.3 China Fatty Liver Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Fatty Liver Drugs Market Size (2019-2030)
9.2 Asia Fatty Liver Drugs Market Size by Type
9.2.1 Asia Fatty Liver Drugs Market Size by Type (2019-2024)
9.2.2 Asia Fatty Liver Drugs Market Size by Type (2025-2030)
9.2.3 Asia Fatty Liver Drugs Market Share by Type (2019-2030)
9.3 Asia Fatty Liver Drugs Market Size by Application
9.3.1 Asia Fatty Liver Drugs Market Size by Application (2019-2024)
9.3.2 Asia Fatty Liver Drugs Market Size by Application (2025-2030)
9.3.3 Asia Fatty Liver Drugs Market Share by Application (2019-2030)
9.4 Asia Fatty Liver Drugs Market Size by Region
9.4.1 Asia Fatty Liver Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Fatty Liver Drugs Market Size by Region (2019-2024)
9.4.3 Asia Fatty Liver Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Fatty Liver Drugs Introduction
11.1.4 Pfizer Revenue in Fatty Liver Drugs Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Fatty Liver Drugs Introduction
11.2.4 Gilead Sciences Revenue in Fatty Liver Drugs Business (2019-2024)
11.2.5 Gilead Sciences Recent Developments
11.3 Astra Zenca
11.3.1 Astra Zenca Company Details
11.3.2 Astra Zenca Business Overview
11.3.3 Astra Zenca Fatty Liver Drugs Introduction
11.3.4 Astra Zenca Revenue in Fatty Liver Drugs Business (2019-2024)
11.3.5 Astra Zenca Recent Developments
11.4 Immuron
11.4.1 Immuron Company Details
11.4.2 Immuron Business Overview
11.4.3 Immuron Fatty Liver Drugs Introduction
11.4.4 Immuron Revenue in Fatty Liver Drugs Business (2019-2024)
11.4.5 Immuron Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Fatty Liver Drugs Introduction
11.5.4 Novartis Revenue in Fatty Liver Drugs Business (2019-2024)
11.5.5 Novartis Recent Developments
11.6 Takeda
11.6.1 Takeda Company Details
11.6.2 Takeda Business Overview
11.6.3 Takeda Fatty Liver Drugs Introduction
11.6.4 Takeda Revenue in Fatty Liver Drugs Business (2019-2024)
11.6.5 Takeda Recent Developments
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview
11.7.3 Allergan Fatty Liver Drugs Introduction
11.7.4 Allergan Revenue in Fatty Liver Drugs Business (2019-2024)
11.7.5 Allergan Recent Developments
11.8 Intercept Pharmaceuticals
11.8.1 Intercept Pharmaceuticals Company Details
11.8.2 Intercept Pharmaceuticals Business Overview
11.8.3 Intercept Pharmaceuticals Fatty Liver Drugs Introduction
11.8.4 Intercept Pharmaceuticals Revenue in Fatty Liver Drugs Business (2019-2024)
11.8.5 Intercept Pharmaceuticals Recent Developments
11.9 Conatus
11.9.1 Conatus Company Details
11.9.2 Conatus Business Overview
11.9.3 Conatus Fatty Liver Drugs Introduction
11.9.4 Conatus Revenue in Fatty Liver Drugs Business (2019-2024)
11.9.5 Conatus Recent Developments
11.10 Merk
11.10.1 Merk Company Details
11.10.2 Merk Business Overview
11.10.3 Merk Fatty Liver Drugs Introduction
11.10.4 Merk Revenue in Fatty Liver Drugs Business (2019-2024)
11.10.5 Merk Recent Developments
11.11 Madrigal
11.11.1 Madrigal Company Details
11.11.2 Madrigal Business Overview
11.11.3 Madrigal Fatty Liver Drugs Introduction
11.11.4 Madrigal Revenue in Fatty Liver Drugs Business (2019-2024)
11.11.5 Madrigal Recent Developments
11.12 Hepion Pharmaceuticals
11.12.1 Hepion Pharmaceuticals Company Details
11.12.2 Hepion Pharmaceuticals Business Overview
11.12.3 Hepion Pharmaceuticals Fatty Liver Drugs Introduction
11.12.4 Hepion Pharmaceuticals Revenue in Fatty Liver Drugs Business (2019-2024)
11.12.5 Hepion Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fatty Liver Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 ALD
1.2.3 NAFLD
1.3 Market by Application
1.3.1 Global Fatty Liver Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fatty Liver Drugs Market Perspective (2019-2030)
2.2 Global Fatty Liver Drugs Growth Trends by Region
2.2.1 Fatty Liver Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fatty Liver Drugs Historic Market Size by Region (2019-2024)
2.2.3 Fatty Liver Drugs Forecasted Market Size by Region (2025-2030)
2.3 Fatty Liver Drugs Market Dynamics
2.3.1 Fatty Liver Drugs Industry Trends
2.3.2 Fatty Liver Drugs Market Drivers
2.3.3 Fatty Liver Drugs Market Challenges
2.3.4 Fatty Liver Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Fatty Liver Drugs by Players
3.1.1 Global Fatty Liver Drugs Revenue by Players (2019-2024)
3.1.2 Global Fatty Liver Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Fatty Liver Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Fatty Liver Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Fatty Liver Drugs Market Concentration Ratio
3.4.1 Global Fatty Liver Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fatty Liver Drugs Revenue in 2023
3.5 Global Key Players of Fatty Liver Drugs Head office and Area Served
3.6 Global Key Players of Fatty Liver Drugs, Product and Application
3.7 Global Key Players of Fatty Liver Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fatty Liver Drugs Breakdown Data by Type
4.1 Global Fatty Liver Drugs Historic Market Size by Type (2019-2024)
4.2 Global Fatty Liver Drugs Forecasted Market Size by Type (2025-2030)
5 Fatty Liver Drugs Breakdown Data by Application
5.1 Global Fatty Liver Drugs Historic Market Size by Application (2019-2024)
5.2 Global Fatty Liver Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fatty Liver Drugs Market Size (2019-2030)
6.2 North America Fatty Liver Drugs Market Size by Type
6.2.1 North America Fatty Liver Drugs Market Size by Type (2019-2024)
6.2.2 North America Fatty Liver Drugs Market Size by Type (2025-2030)
6.2.3 North America Fatty Liver Drugs Market Share by Type (2019-2030)
6.3 North America Fatty Liver Drugs Market Size by Application
6.3.1 North America Fatty Liver Drugs Market Size by Application (2019-2024)
6.3.2 North America Fatty Liver Drugs Market Size by Application (2025-2030)
6.3.3 North America Fatty Liver Drugs Market Share by Application (2019-2030)
6.4 North America Fatty Liver Drugs Market Size by Country
6.4.1 North America Fatty Liver Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Fatty Liver Drugs Market Size by Country (2019-2024)
6.4.3 North America Fatty Liver Drugs Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Fatty Liver Drugs Market Size (2019-2030)
7.2 Europe Fatty Liver Drugs Market Size by Type
7.2.1 Europe Fatty Liver Drugs Market Size by Type (2019-2024)
7.2.2 Europe Fatty Liver Drugs Market Size by Type (2025-2030)
7.2.3 Europe Fatty Liver Drugs Market Share by Type (2019-2030)
7.3 Europe Fatty Liver Drugs Market Size by Application
7.3.1 Europe Fatty Liver Drugs Market Size by Application (2019-2024)
7.3.2 Europe Fatty Liver Drugs Market Size by Application (2025-2030)
7.3.3 Europe Fatty Liver Drugs Market Share by Application (2019-2030)
7.4 Europe Fatty Liver Drugs Market Size by Country
7.4.1 Europe Fatty Liver Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Fatty Liver Drugs Market Size by Country (2019-2024)
7.4.3 Europe Fatty Liver Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Fatty Liver Drugs Market Size (2019-2030)
8.2 China Fatty Liver Drugs Market Size by Type
8.2.1 China Fatty Liver Drugs Market Size by Type (2019-2024)
8.2.2 China Fatty Liver Drugs Market Size by Type (2025-2030)
8.2.3 China Fatty Liver Drugs Market Share by Type (2019-2030)
8.3 China Fatty Liver Drugs Market Size by Application
8.3.1 China Fatty Liver Drugs Market Size by Application (2019-2024)
8.3.2 China Fatty Liver Drugs Market Size by Application (2025-2030)
8.3.3 China Fatty Liver Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Fatty Liver Drugs Market Size (2019-2030)
9.2 Asia Fatty Liver Drugs Market Size by Type
9.2.1 Asia Fatty Liver Drugs Market Size by Type (2019-2024)
9.2.2 Asia Fatty Liver Drugs Market Size by Type (2025-2030)
9.2.3 Asia Fatty Liver Drugs Market Share by Type (2019-2030)
9.3 Asia Fatty Liver Drugs Market Size by Application
9.3.1 Asia Fatty Liver Drugs Market Size by Application (2019-2024)
9.3.2 Asia Fatty Liver Drugs Market Size by Application (2025-2030)
9.3.3 Asia Fatty Liver Drugs Market Share by Application (2019-2030)
9.4 Asia Fatty Liver Drugs Market Size by Region
9.4.1 Asia Fatty Liver Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Fatty Liver Drugs Market Size by Region (2019-2024)
9.4.3 Asia Fatty Liver Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Fatty Liver Drugs Introduction
11.1.4 Pfizer Revenue in Fatty Liver Drugs Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Fatty Liver Drugs Introduction
11.2.4 Gilead Sciences Revenue in Fatty Liver Drugs Business (2019-2024)
11.2.5 Gilead Sciences Recent Developments
11.3 Astra Zenca
11.3.1 Astra Zenca Company Details
11.3.2 Astra Zenca Business Overview
11.3.3 Astra Zenca Fatty Liver Drugs Introduction
11.3.4 Astra Zenca Revenue in Fatty Liver Drugs Business (2019-2024)
11.3.5 Astra Zenca Recent Developments
11.4 Immuron
11.4.1 Immuron Company Details
11.4.2 Immuron Business Overview
11.4.3 Immuron Fatty Liver Drugs Introduction
11.4.4 Immuron Revenue in Fatty Liver Drugs Business (2019-2024)
11.4.5 Immuron Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Fatty Liver Drugs Introduction
11.5.4 Novartis Revenue in Fatty Liver Drugs Business (2019-2024)
11.5.5 Novartis Recent Developments
11.6 Takeda
11.6.1 Takeda Company Details
11.6.2 Takeda Business Overview
11.6.3 Takeda Fatty Liver Drugs Introduction
11.6.4 Takeda Revenue in Fatty Liver Drugs Business (2019-2024)
11.6.5 Takeda Recent Developments
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview
11.7.3 Allergan Fatty Liver Drugs Introduction
11.7.4 Allergan Revenue in Fatty Liver Drugs Business (2019-2024)
11.7.5 Allergan Recent Developments
11.8 Intercept Pharmaceuticals
11.8.1 Intercept Pharmaceuticals Company Details
11.8.2 Intercept Pharmaceuticals Business Overview
11.8.3 Intercept Pharmaceuticals Fatty Liver Drugs Introduction
11.8.4 Intercept Pharmaceuticals Revenue in Fatty Liver Drugs Business (2019-2024)
11.8.5 Intercept Pharmaceuticals Recent Developments
11.9 Conatus
11.9.1 Conatus Company Details
11.9.2 Conatus Business Overview
11.9.3 Conatus Fatty Liver Drugs Introduction
11.9.4 Conatus Revenue in Fatty Liver Drugs Business (2019-2024)
11.9.5 Conatus Recent Developments
11.10 Merk
11.10.1 Merk Company Details
11.10.2 Merk Business Overview
11.10.3 Merk Fatty Liver Drugs Introduction
11.10.4 Merk Revenue in Fatty Liver Drugs Business (2019-2024)
11.10.5 Merk Recent Developments
11.11 Madrigal
11.11.1 Madrigal Company Details
11.11.2 Madrigal Business Overview
11.11.3 Madrigal Fatty Liver Drugs Introduction
11.11.4 Madrigal Revenue in Fatty Liver Drugs Business (2019-2024)
11.11.5 Madrigal Recent Developments
11.12 Hepion Pharmaceuticals
11.12.1 Hepion Pharmaceuticals Company Details
11.12.2 Hepion Pharmaceuticals Business Overview
11.12.3 Hepion Pharmaceuticals Fatty Liver Drugs Introduction
11.12.4 Hepion Pharmaceuticals Revenue in Fatty Liver Drugs Business (2019-2024)
11.12.5 Hepion Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Fatty Liver Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of ALD
Table 3. Key Players of NAFLD
Table 4. Global Fatty Liver Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Fatty Liver Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Fatty Liver Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Fatty Liver Drugs Market Share by Region (2019-2024)
Table 8. Global Fatty Liver Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Fatty Liver Drugs Market Share by Region (2025-2030)
Table 10. Fatty Liver Drugs Market Trends
Table 11. Fatty Liver Drugs Market Drivers
Table 12. Fatty Liver Drugs Market Challenges
Table 13. Fatty Liver Drugs Market Restraints
Table 14. Global Fatty Liver Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Fatty Liver Drugs Revenue Share by Players (2019-2024)
Table 16. Global Top Fatty Liver Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Drugs as of 2023)
Table 17. Global Fatty Liver Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Fatty Liver Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Fatty Liver Drugs, Headquarters and Area Served
Table 20. Global Key Players of Fatty Liver Drugs, Product and Application
Table 21. Global Key Players of Fatty Liver Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Fatty Liver Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Fatty Liver Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Fatty Liver Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Fatty Liver Drugs Revenue Share by Application (2019-2024)
Table 29. Global Fatty Liver Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Fatty Liver Drugs Revenue Share by Application (2025-2030)
Table 31. North America Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Fatty Liver Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Fatty Liver Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Fatty Liver Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Fatty Liver Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Fatty Liver Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Fatty Liver Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Fatty Liver Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Fatty Liver Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Fatty Liver Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Fatty Liver Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Fatty Liver Drugs Product
Table 66. Pfizer Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 67. Pfizer Recent Developments
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences Fatty Liver Drugs Product
Table 71. Gilead Sciences Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 72. Gilead Sciences Recent Developments
Table 73. Astra Zenca Company Details
Table 74. Astra Zenca Business Overview
Table 75. Astra Zenca Fatty Liver Drugs Product
Table 76. Astra Zenca Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 77. Astra Zenca Recent Developments
Table 78. Immuron Company Details
Table 79. Immuron Business Overview
Table 80. Immuron Fatty Liver Drugs Product
Table 81. Immuron Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 82. Immuron Recent Developments
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Fatty Liver Drugs Product
Table 86. Novartis Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 87. Novartis Recent Developments
Table 88. Takeda Company Details
Table 89. Takeda Business Overview
Table 90. Takeda Fatty Liver Drugs Product
Table 91. Takeda Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 92. Takeda Recent Developments
Table 93. Allergan Company Details
Table 94. Allergan Business Overview
Table 95. Allergan Fatty Liver Drugs Product
Table 96. Allergan Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 97. Allergan Recent Developments
Table 98. Intercept Pharmaceuticals Company Details
Table 99. Intercept Pharmaceuticals Business Overview
Table 100. Intercept Pharmaceuticals Fatty Liver Drugs Product
Table 101. Intercept Pharmaceuticals Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 102. Intercept Pharmaceuticals Recent Developments
Table 103. Conatus Company Details
Table 104. Conatus Business Overview
Table 105. Conatus Fatty Liver Drugs Product
Table 106. Conatus Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 107. Conatus Recent Developments
Table 108. Merk Company Details
Table 109. Merk Business Overview
Table 110. Merk Fatty Liver Drugs Product
Table 111. Merk Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 112. Merk Recent Developments
Table 113. Madrigal Company Details
Table 114. Madrigal Business Overview
Table 115. Madrigal Fatty Liver Drugs Product
Table 116. Madrigal Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 117. Madrigal Recent Developments
Table 118. Hepion Pharmaceuticals Company Details
Table 119. Hepion Pharmaceuticals Business Overview
Table 120. Hepion Pharmaceuticals Fatty Liver Drugs Product
Table 121. Hepion Pharmaceuticals Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 122. Hepion Pharmaceuticals Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fatty Liver Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Fatty Liver Drugs Market Share by Type: 2023 VS 2030
Figure 3. ALD Features
Figure 4. NAFLD Features
Figure 5. Global Fatty Liver Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Fatty Liver Drugs Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Fatty Liver Drugs Report Years Considered
Figure 11. Global Fatty Liver Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Fatty Liver Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Fatty Liver Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Fatty Liver Drugs Market Share by Players in 2023
Figure 15. Global Top Fatty Liver Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Fatty Liver Drugs Revenue in 2023
Figure 17. North America Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 19. North America Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 20. North America Fatty Liver Drugs Market Share by Country (2019-2030)
Figure 21. United States Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Fatty Liver Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 25. Europe Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 26. Europe Fatty Liver Drugs Market Share by Country (2019-2030)
Figure 27. Germany Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Fatty Liver Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 35. China Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 36. Asia Fatty Liver Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 38. Asia Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 39. Asia Fatty Liver Drugs Market Share by Region (2019-2030)
Figure 40. Japan Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Country (2019-2030)
Figure 50. Brazil Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 57. Gilead Sciences Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 58. Astra Zenca Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 59. Immuron Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 60. Novartis Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 61. Takeda Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 62. Allergan Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 63. Intercept Pharmaceuticals Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 64. Conatus Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 65. Merk Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 66. Madrigal Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 67. Hepion Pharmaceuticals Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Fatty Liver Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of ALD
Table 3. Key Players of NAFLD
Table 4. Global Fatty Liver Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Fatty Liver Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Fatty Liver Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Fatty Liver Drugs Market Share by Region (2019-2024)
Table 8. Global Fatty Liver Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Fatty Liver Drugs Market Share by Region (2025-2030)
Table 10. Fatty Liver Drugs Market Trends
Table 11. Fatty Liver Drugs Market Drivers
Table 12. Fatty Liver Drugs Market Challenges
Table 13. Fatty Liver Drugs Market Restraints
Table 14. Global Fatty Liver Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Fatty Liver Drugs Revenue Share by Players (2019-2024)
Table 16. Global Top Fatty Liver Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Drugs as of 2023)
Table 17. Global Fatty Liver Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Fatty Liver Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Fatty Liver Drugs, Headquarters and Area Served
Table 20. Global Key Players of Fatty Liver Drugs, Product and Application
Table 21. Global Key Players of Fatty Liver Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Fatty Liver Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Fatty Liver Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Fatty Liver Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Fatty Liver Drugs Revenue Share by Application (2019-2024)
Table 29. Global Fatty Liver Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Fatty Liver Drugs Revenue Share by Application (2025-2030)
Table 31. North America Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Fatty Liver Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Fatty Liver Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Fatty Liver Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Fatty Liver Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Fatty Liver Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Fatty Liver Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Fatty Liver Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Fatty Liver Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Fatty Liver Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Fatty Liver Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Fatty Liver Drugs Product
Table 66. Pfizer Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 67. Pfizer Recent Developments
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences Fatty Liver Drugs Product
Table 71. Gilead Sciences Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 72. Gilead Sciences Recent Developments
Table 73. Astra Zenca Company Details
Table 74. Astra Zenca Business Overview
Table 75. Astra Zenca Fatty Liver Drugs Product
Table 76. Astra Zenca Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 77. Astra Zenca Recent Developments
Table 78. Immuron Company Details
Table 79. Immuron Business Overview
Table 80. Immuron Fatty Liver Drugs Product
Table 81. Immuron Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 82. Immuron Recent Developments
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Fatty Liver Drugs Product
Table 86. Novartis Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 87. Novartis Recent Developments
Table 88. Takeda Company Details
Table 89. Takeda Business Overview
Table 90. Takeda Fatty Liver Drugs Product
Table 91. Takeda Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 92. Takeda Recent Developments
Table 93. Allergan Company Details
Table 94. Allergan Business Overview
Table 95. Allergan Fatty Liver Drugs Product
Table 96. Allergan Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 97. Allergan Recent Developments
Table 98. Intercept Pharmaceuticals Company Details
Table 99. Intercept Pharmaceuticals Business Overview
Table 100. Intercept Pharmaceuticals Fatty Liver Drugs Product
Table 101. Intercept Pharmaceuticals Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 102. Intercept Pharmaceuticals Recent Developments
Table 103. Conatus Company Details
Table 104. Conatus Business Overview
Table 105. Conatus Fatty Liver Drugs Product
Table 106. Conatus Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 107. Conatus Recent Developments
Table 108. Merk Company Details
Table 109. Merk Business Overview
Table 110. Merk Fatty Liver Drugs Product
Table 111. Merk Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 112. Merk Recent Developments
Table 113. Madrigal Company Details
Table 114. Madrigal Business Overview
Table 115. Madrigal Fatty Liver Drugs Product
Table 116. Madrigal Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 117. Madrigal Recent Developments
Table 118. Hepion Pharmaceuticals Company Details
Table 119. Hepion Pharmaceuticals Business Overview
Table 120. Hepion Pharmaceuticals Fatty Liver Drugs Product
Table 121. Hepion Pharmaceuticals Revenue in Fatty Liver Drugs Business (2019-2024) & (US$ Million)
Table 122. Hepion Pharmaceuticals Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fatty Liver Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Fatty Liver Drugs Market Share by Type: 2023 VS 2030
Figure 3. ALD Features
Figure 4. NAFLD Features
Figure 5. Global Fatty Liver Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Fatty Liver Drugs Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Fatty Liver Drugs Report Years Considered
Figure 11. Global Fatty Liver Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Fatty Liver Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Fatty Liver Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Fatty Liver Drugs Market Share by Players in 2023
Figure 15. Global Top Fatty Liver Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Fatty Liver Drugs Revenue in 2023
Figure 17. North America Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 19. North America Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 20. North America Fatty Liver Drugs Market Share by Country (2019-2030)
Figure 21. United States Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Fatty Liver Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 25. Europe Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 26. Europe Fatty Liver Drugs Market Share by Country (2019-2030)
Figure 27. Germany Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Fatty Liver Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 35. China Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 36. Asia Fatty Liver Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 38. Asia Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 39. Asia Fatty Liver Drugs Market Share by Region (2019-2030)
Figure 40. Japan Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Fatty Liver Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Fatty Liver Drugs Market Share by Country (2019-2030)
Figure 50. Brazil Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Fatty Liver Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 57. Gilead Sciences Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 58. Astra Zenca Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 59. Immuron Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 60. Novartis Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 61. Takeda Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 62. Allergan Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 63. Intercept Pharmaceuticals Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 64. Conatus Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 65. Merk Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 66. Madrigal Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 67. Hepion Pharmaceuticals Revenue Growth Rate in Fatty Liver Drugs Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232